Molina Healthcare (NYSE:MOH) Posts Quarterly Earnings Results, Beats Estimates By $0.19 EPS

Molina Healthcare (NYSE:MOH) released its quarterly earnings results on Wednesday. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.16 by $0.19, FiscalAI reports. The business had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%. Molina Healthcare updated its FY 2026 guidance to 5.000- EPS.

Molina Healthcare Price Performance

MOH stock traded up $2.03 during trading on Wednesday, hitting $153.03. The stock had a trading volume of 2,627,482 shares, compared to its average volume of 1,763,997. The company’s 50 day moving average price is $143.54 and its two-hundred day moving average price is $159.39. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $333.22. The stock has a market cap of $7.97 billion, a price-to-earnings ratio of 17.88 and a beta of 0.55. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.69 and a current ratio of 1.69.

Analyst Ratings Changes

Several research firms have recently issued reports on MOH. Wells Fargo & Company set a $141.00 price target on Molina Healthcare and gave the stock an “equal weight” rating in a research note on Friday, February 20th. The Goldman Sachs Group cut their price target on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research note on Wednesday, February 11th. Deutsche Bank Aktiengesellschaft set a $310.00 price target on Molina Healthcare in a research note on Friday, March 13th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a research note on Thursday, January 22nd. Finally, Wall Street Zen raised Molina Healthcare from a “strong sell” rating to a “sell” rating in a research note on Sunday. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Molina Healthcare presently has an average rating of “Hold” and an average price target of $169.21.

Key Stories Impacting Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina reported an EPS beat for Q1: $2.35 vs. consensus $2.16, showing better-than-expected profitability on the bottom line. This likely supported the stock’s upside. Press Release
• Positive Sentiment: Analyst actions are mixed-to-helpful: Zacks upgraded MOH from “strong sell” to “hold,” reducing immediate downside sentiment. Zacks
• Positive Sentiment: Mizuho reiterated a Buy rating, providing continued institutional support for the name. Mizuho Buy Coverage
• Positive Sentiment: Several bullish commentaries frame MOH as a longer-term buying opportunity after recent weakness and a prior rally, which may attract buy-side interest. Seeking Alpha
• Neutral Sentiment: Pre- and post-earnings coverage is focused on whether new Medicare rate changes will boost results — this is speculative and could be a catalyst if confirmed in future quarters. 247WallSt
• Neutral Sentiment: Coverage questioning valuation after a big one-year rally prompts re‑assessment risk; such articles can increase volatility but are not direct fundamental changes. Yahoo Finance
• Neutral Sentiment: Jefferies issued a Hold, which is neither bullish nor bearish but may temper upside expectations. Jefferies/Hold
• Negative Sentiment: FY‑2026 EPS guidance was set at 5.00 (vs. consensus ~5.04), a modest shortfall to expectations — investors often penalize guidance misses more than one-off beats.
• Negative Sentiment: Revenue slightly missed estimates: $10.80B vs. $10.91B consensus, which raises questions about topline momentum even as EPS outperformed.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Sivia Capital Partners LLC raised its stake in Molina Healthcare by 165.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,935 shares of the company’s stock valued at $576,000 after purchasing an additional 1,207 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. increased its stake in shares of Molina Healthcare by 44.2% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 1,462 shares of the company’s stock valued at $280,000 after acquiring an additional 448 shares during the last quarter. United Capital Financial Advisors LLC increased its stake in shares of Molina Healthcare by 42.9% during the 3rd quarter. United Capital Financial Advisors LLC now owns 1,448 shares of the company’s stock valued at $277,000 after acquiring an additional 435 shares during the last quarter. Nomura Holdings Inc. acquired a new position in shares of Molina Healthcare during the 3rd quarter valued at about $268,000. Finally, Beacon Pointe Advisors LLC increased its stake in shares of Molina Healthcare by 9.9% during the 4th quarter. Beacon Pointe Advisors LLC now owns 1,416 shares of the company’s stock valued at $246,000 after acquiring an additional 128 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.